What is Astal Laboratories Ltd (512600) share price return in the past 10 years?

Astal Laboratories Ltd share price has appreciated 13.4% annually (CAGR) over the past ten years.

What is the share price of Astal Laboratories Ltd (512600)?

Company share prices are keep on changing according to the market conditions. The current trading price of Astal Laboratories Ltd (512600) on 12-Jun-2026 16:59:59 at 16:59 is 77.28.

What is the P/E ratio of Astal Laboratories?

The latest standalone P/E ratio of Astal Laboratories as of 12-Jun-2026 is 41.96.

What is the P/B ratio of Astal Laboratories Ltd (512600)?

The latest standalone P/B ratio of Astal Laboratories Ltd (512600) as of 12-Jun-2026 is 1.02.

What is the 52-week high and low of Astal Laboratories Ltd (512600)?

The 52-week high of Astal Laboratories Ltd (512600) is Rs. 103.20 and the 52-week low is Rs. 60.45.

Astal Laboratories Ltd (512600) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Astal Laboratories Ltd (512600)
Brand: Astal Laboratories

Astal Laboratories Ltd (512600)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 512600 NSE: Pharmaceuticals & Drugs | Small Cap | Astal Laboratories Share Price

Astal Laboratories Ltd (512600)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 512600 NSE: Pharmaceuticals & Drugs | Small Cap | Astal Laboratories Share Price

Key Metrics

Valuation Multiples

Market Cap

₹341 Cr.

Current Price

₹77.3

52-Week Low / High

₹60 / 103

TTM EPS

₹1.9

TTM Sales

₹156 Cr.

Book Value per Share

₹76.1

P/E Ratio

41.96

Higher than its 5-year historical median

Industry PE

46.9

Price to Book (P/B)

1.02

Lower than its 5-year historical median

Price to Sales (P/S)

2.18

Higher than its 5-year historical median

EV/EBITDA

27.14

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

32.12%

Outperforms industry median

Return on Capital Employed (ROCE)

34.78%

Outperforms industry median

Return on Assets (ROA)

17.86%

Operating Profit Margin

19.9%

Net Profit Margin

13.9%

Gross Profit Margin

19%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

171.59%

Operating Profit Growth (1 Year)

1051.35%

Net Profit Growth (1 Year)

1044.87%

Asset Quality

Promoter Holding

4.70%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹290 Cr.

Equity

₹43.8 Cr.

Face Value

₹10

All Time Low / High

₹4.05 / 131.70

Astal Laboratories stock performance

Key Ratios

Check Before You Invest

Quality

Not Good

Check detailed performance

Valuation

Undervalued

Check Valuation charts

Price Trend

Weak

Check Price chart

Q.1 Is Astal Laboratories Ltd a good quality company?

Astal Laboratories Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Astal Laboratories Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Astal Laboratories Ltd vs industry peers?

Astal Laboratories Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 6.81%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Astal Laboratories Ltd?

Promoters hold 4.70% of the Astal Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Astal Laboratories Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 13.3% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0.4%	0.2%	-0.1%	-1.4%	-0.5%	0.2%	-0.3%	0.6%	7.6%	34.8%	-
Value Creation Index ⓘ	-1.0	-1.0	-1.0	-1.1	-1.0	-1.0	-1.0	-1.0	-0.5	1.5	-
Growth Parameters ⓘ
Sales ⓘ	0	0	0	0	0	0	0	3.4	23.7	64.2	156
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	589.5%	171.6%	-
Adj EPS ⓘ	0.1	0	-0	-0.2	-0.1	0	-0	0	0.8	9.1	1.9
YoY Gr.	-	-80%	-300%	NA	NA	NA	-250%	NA	1900%	1035%	-
BVPS (₹) ⓘ	13.3	13.3	13.3	13	13	13	13	13	23.7	32.8	76.1
Adj Net Profit ⓘ	0	0	-0	-0.1	-0	0	-0	0	0.8	8.9	8
Cash Flow from Ops. ⓘ	-0.2	-0.3	-0.3	-0.3	-0.2	-0.2	-0.3	-1.4	-5.6	-12.5	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	-0.1	-1.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	171.6%
Adj EPS ⓘ	78.2%	NA	NA	1035%
BVPSⓘ	10.6%	20.4%	36.3%	38.3%
Share Price	13.4%	54.6%	36.3%	-9.4%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.3	0.1	-0.1	-1.6	-0.5	0.1	-0.3	0.3	5.5	30.1	3.4
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	0	-4.1	4.7	19.9	8.2
Net Profit Mgn % ⓘ	0	0	0	0	0	0	0	0.5	3.3	13.9	5.2
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0.4	0
Working Cap Days ⓘ	0	0	0	0	0	0	0	799	306	227	108
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	0	-30	31	87	35

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	0	0	0	0	0	0	3	24	64
Operating Expenses ⓘ +	0	0	0	0	0	0	0	4	23	51
Manufacturing Costs	0	0	0	0	0	0	0	0	0	1
Material Costs	0	0	0	0	0	0	0	3	21	48
Employee Cost	0	0	0	0	0	0	0	0	0	1
Other Costs ⓘ	0	0	0	0	0	0	0	0	1	2
Operating Profit ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	1	13
Operating Profit Margin (%)	-	-	-	-	-	-	-	-4.1%	4.7%	19.9%
Other Income ⓘ +	0	0	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	1
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0	-0	-0	-0	0	-0	0	1	12
Tax ⓘ	0	0	0	0	0	0	0	0	0	3
Profit After Tax	0	0	-0	-0	-0	0	-0	0	1	9
PAT Margin (%)	-	-	-	-	-	-	-	0.5%	3.3%	13.9%
Adjusted EPS (₹)	0.0	0.0	-0.0	-0.2	-0.1	0.0	-0.0	0.0	0.8	9.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Astal Laboratories - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	5	5	5	5	5	5	5	5	23	32
Share Capital ⓘ	4	4	4	4	4	4	4	4	10	10
Reserves ⓘ	1	1	1	1	1	1	1	1	13	22
Debt +	0	0	0	0	0	0	0	0	0	13
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	13
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0	4	12	11
Others Liabilities ⓘ	0	0	0	0	0	0	0	1	2	7
Total Liabilities ⓘ	5	5	5	5	5	5	5	10	37	63
Fixed Assets
Net Fixed Assets ⓘ +	0	0	0	0	0	0	0	0	1	11
Gross Block	0	0	0	0	0	0	0	0	1	12
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0	0	0	0	0	0	0	0	1	15
Trade Receivables	0	0	0	0	0	0	0	3	16	28
Cash Equivalents	0	0	0	0	0	0	0	0	6	2
Others Assets ⓘ	5	5	5	5	5	5	5	7	13	8
Total Assets ⓘ	5	5	5	5	5	5	5	10	37	63

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0	-0	-0	-0	-0	-0	-0	-1	-6	-13
PBT ⓘ	0	0	-0	-0	-0	0	-0	0	1	12
Adjustment ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	0	1
Changes in Working Capital ⓘ	0	-0	0	0	0	-0	-0	-1	-7	-25
Tax Paid ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Cash Flow From Investing Activity ⓘ +	0	0	0	0	0	0	0	2	-6	-8
Capex	-0	0	-0	0	0	0	0	0	-1	-6
Net Investments	0	0	0	0	0	0	0	0	0	-2
Others ⓘ	0	0	0	0	0	0	0	2	-5	0
Cash Flow From Financing Activity ⓘ +	0	0	0	0	0	0	0	0	18	3
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	17	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	-0	-1
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	4
Net Cash Flow ⓘ	0	0	-0	0	0	0	-0	0	6	-17

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.16	0.1	-0.13	-1.57	-0.54	0.12	-0.33	0.32	5.51	32.12
ROCE (%)	0.36	0.2	-0.09	-1.44	-0.54	0.16	-0.33	0.62	7.62	34.78
Asset Turnover Ratio	0	0	0	0	0	0	0	0.45	1.02	1.29
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-6	-1.44
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	337	146.50	123.50
Inventory Days	0	0	0	0	0	0	0	0	16.30	44.90
Payable Days	0	0	0	0	0	0	0	412.70	130.90	84.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Astal Laboratories Ltd FAQs

The current trading price of Astal Laboratories on 12-Jun-2026 16:59 is ₹77.28.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Jun-2026 the market cap of Astal Laboratories stood at ₹340.6 Cr

The latest P/E ratio of Astal Laboratories as of 11-Jun-2026 is 41.96.

The latest P/B ratio of Astal Laboratories as of 11-Jun-2026 is 1.02.

The 52-week high of Astal Laboratories is ₹103.2 and the 52-week low is ₹60.45.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Astal Laboratories is ₹156 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Astal Laboratories Ltd is a below average quality company.

The key valuation ratios of Astal Laboratories Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Astal Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Astal Laboratories Ltd

No data to display

Astal Laboratories Ltd (512600)

Astal Laboratories Ltd (512600)

Astal Laboratories stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Astal Laboratories - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Astal Laboratories Ltd FAQs

About Astal Laboratories Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Astal Laboratories Ltd (512600)

Astal Laboratories Ltd (512600)

Astal Laboratories stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Astal Laboratories - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Astal Laboratories Ltd FAQs

What is the share price of Astal Laboratories?

What is the market cap of Astal Laboratories?

What is the P/E ratio of Astal Laboratories?

What is the P/B ratio of Astal Laboratories?

What is the 52-week high and low of Astal Laboratories?

What is the TTM revenue of Astal Laboratories?

Is Astal Laboratories Ltd a good quality company?

Is Astal Laboratories Ltd undervalued or overvalued?

Is Astal Laboratories Ltd a good buy now?

About Astal Laboratories Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.